Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis - No Study Results Posted

Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis (CBD-CT1)

This study has been completed.

Study NCT00628290 Information provided by University of Cologne

First Received: February 26, 2008 Last Updated: March 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2008
Primary Completion Date:	November 2004 (Final data collection date for primary outcome measure)